Connect with BUHLMANN at CDDW 2019!

CDDW 2019

Canadian Digestive Diseases Week (CDDW) 2019

BUHLMANN Diagnostics Corp
Booth: #116
Mar 1 – 3, 2019 | Fairmont Banff Springs Hotel | Banff Alberta

Visit our booth to get an update on our Calprotectin and Therapeutic Drug Monitoring product portfolio:

  • IBDoc®, the ONLY in-vitro diagnostic POC and home testing device to measure the inflammatory marker, fecal calprotectin

    Health Canada License: 98903, Device class: 3
     US: Not available for Sale in the US.

    Health Canada Licenses: Quantum Blue®  fCAL: 83477, Quantum Blue® Infliximab:        98838, Quantum Blue® Adalimumab: 101776
     US: Research Use Only. Not for use in diagnostic procedures in the US

Click & Contact CDDW 2019 BUHLMANN Team

Connect with our team ahead of time, learn more about our assays or schedule a meeting!

Collin Shaw, VP of Business Development

VP of Business Development